This Solicitation opportunity from Maryland was posted on November 19, 2024. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
MHCC 25-01 Actuarial Consulting - Elimination of Step Therapy for Metastatic Cancer Side Effect Tre
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The Maryland Health Care Commission is seeking a contractor to analyze and recommend the elimination of step therapy requirements imposed by health insurers, nonprofit health service plans, and health maintenance organizations for treatments related to metastatic cancer and its associated side effects. Since metastatic cancer has no known cure, treatment focuses on prolonging life and alleviating symptoms, often involving multiple drugs to manage side effects such as pain, nausea, fatigue, and immune system issues. Currently, some health plans enforce step therapy protocols that require patients to undergo initial, often less effective or less appropriate treatments before receiving the prescribed optimal therapy, leading to delays, increased stress, and potentially adverse health outcomes for patients. The removal of these step therapy barriers aims to streamline access to necessary medications, reduce treatment delays, and improve patient quality of life by allowing oncologists to directly prescribe the most suitable drugs without navigating complex prior authorization processes involving documentation from patients, families, and healthcare providers. The contract, valued between $500,000 and $1,500,000, is issued by the Maryland Department of Health and is set to be posted in November 2024, with responses due by early December 2024. The project emphasizes a comprehensive review of current step therapy policies and their impact on metastatic cancer treatment, with the goal of informing policy changes that prioritize patient well-being and treatment efficacy. The selected contractor will work closely with the Maryland Boards & Commissions Department of Health, and contact for inquiries is Andrea Allen. The initiative aligns with broader efforts to improve healthcare delivery and reduce unnecessary treatment barriers for cancer patients within Maryland.
General Info
Place of Performance
MD, USASet-Aside
Documents
2AI Contract Breakdown
Uniform Contract FormatContract not broken down yet
CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.
Timeline
Submission Closed
Organization & Contact Information
Full Description
Earlier notices in this NAICS code
Posted before this notice, open and closed
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
